Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position of the European Society of Gene Therapy (ESGT). (Q45859682)
Jump to navigation
Jump to search
scientific article published in March 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position of the European Society of Gene Therapy (ESGT). |
scientific article published in March 2003 |
Statements
1 reference
Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position of the European Society of Gene Therapy (ESGT). (English)
1 reference
Bernd Gansbacher
1 reference
European Society of Gene Therapy
1 reference
1 March 2003
1 reference
5
1 reference
3
1 reference
261-262
1 reference
Identifiers
1 reference